Related references
Note: Only part of the references are listed.Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis
Sam Loveless et al.
BRAIN PATHOLOGY (2018)
Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
Xuan Yuan et al.
HAEMATOLOGICA (2017)
Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome
Xuan Yuan et al.
HAEMATOLOGICA (2017)
The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease
Angharad R. Morgan et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease
Rudy Chang et al.
MOLECULAR PHARMACEUTICS (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Qiaoqiao Shi et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Neurovascular Unit Dysfunction and Blood-Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical integration of Clinical and experimental evidence
Souhel Najjar et al.
FRONTIERS IN PSYCHIATRY (2017)
Peripheral complement interactions with amyloid β peptide: Erythrocyte clearance mechanisms
William D. Brubaker et al.
ALZHEIMERS & DEMENTIA (2017)
The blood-brain barrier in systemic inflammation
Aravinthan Varatharaj et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease
Deng-Feng Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions
Masaki Ueno et al.
BRAIN TUMOR PATHOLOGY (2016)
Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease
Svetlana Hakobyan et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Complement is activated in progressive multiple sclerosis cortical grey matter lesions
Lewis M. Watkins et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Soyon Hong et al.
SCIENCE (2016)
C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy
Rhona McGonigal et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function
Maria I. Fonseca et al.
PLOS ONE (2016)
Convergent genetic and expression data implicate immunity in Alzheimer's disease
Lesley Jones et al.
ALZHEIMERS & DEMENTIA (2015)
Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement
Ali Alawieh et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline
Qiaoqiao Shi et al.
JOURNAL OF NEUROSCIENCE (2015)
Complement, a target for therapy in inflammatory and degenerative diseases
B. Paul Morgan et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Alzheimer's disease is associated with low density of the long CR1 isoform
Rachid Mahmoudi et al.
NEUROBIOLOGY OF AGING (2015)
Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases
Marc Fakhoury
NEURODEGENERATIVE DISEASES (2015)
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
Axel Montagne et al.
NEURON (2015)
Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease
Wesley Jongbloed et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Developing novel blood-based biomarkers for Alzheimer's disease
Heather M. Snyder et al.
ALZHEIMERS & DEMENTIA (2014)
Microglial dysfunction in brain aging and Alzheimer's disease
Kira Irving Mosher et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Altered cognitive performance and synaptic function in the hippocampus of mice lacking C3
Marta Perez-Alcazar et al.
EXPERIMENTAL NEUROLOGY (2014)
Intracellular Clusterin Interacts with Brain Isoforms of the Bridging Integrator 1 and with the Microtubule-Associated Protein Tau in Alzheimer's Disease
Yuan Zhou et al.
PLOS ONE (2014)
Genetic mouse models of brain ageing and Alzheimer's disease
Andras Bilkei-Gorzo
PHARMACOLOGY & THERAPEUTICS (2014)
Microglia in Alzheimer's Disease
Ying Li et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis
Gillian Ingram et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Remodeling of dendrites and spines in the C1q knockout model of genetic epilepsy
Yunyong Ma et al.
EPILEPSIA (2013)
A Dramatic Increase of C1q Protein in the CNS during Normal Aging
Alexander H. Stephan et al.
JOURNAL OF NEUROSCIENCE (2013)
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Sean J. Pittock et al.
LANCET NEUROLOGY (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model
Shuko Takeda et al.
NEUROBIOLOGY OF AGING (2013)
Role of complement and perspectives for intervention in ischemia-reperfusion damage
Yara Banz et al.
ANNALS OF MEDICINE (2012)
Reduced removal of synaptic terminals from axotomized spinal motoneurons in the absence of complement C3
Alexander Berg et al.
EXPERIMENTAL NEUROLOGY (2012)
Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment
Madhav Thambisetty et al.
NEUROIMAGE (2012)
Animal Models of Alzheimer Disease
Frank M. LaFerla et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD
Robert Veerhuis
CURRENT ALZHEIMER RESEARCH (2011)
Plasma Clusterin and the Risk of Alzheimer Disease
Elisabeth M. C. Schrijvers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
Madhav Thambisetty et al.
PLOS ONE (2011)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Lesley Jones et al.
PLOS ONE (2010)
Enhanced synaptic connectivity and epilepsy in C1q knockout mice
Yunxiang Chu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Alzheimer's disease drug development and the problem of the blood-brain barrier
William A. Pardridge
ALZHEIMERS & DEMENTIA (2009)
Lipopolysaccharide alters the blood-brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer's disease
Laura B. Jaeger et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity
Agustin Tortajada et al.
HUMAN MOLECULAR GENETICS (2009)
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Complement C3 deficiency leads to accelerated amyloid β plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice
Marcel Maier et al.
JOURNAL OF NEUROSCIENCE (2008)
Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: A potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease
Douglas G. Walker et al.
MICROVASCULAR RESEARCH (2008)
The classical complement cascade mediates CNS synapse elimination
Beth Stevens et al.
CELL (2007)
Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and Aβ fibril disaggregation
Ruben J. Boado et al.
BIOCONJUGATE CHEMISTRY (2007)
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
GS Hageman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Complement factor H variant increases the risk of age-related macular degeneration
JL Haines et al.
SCIENCE (2005)
Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease
MI Fonseca et al.
JOURNAL OF NEUROSCIENCE (2004)
The possible role of complement activation in Alzheimer disease
PL McGeer et al.
TRENDS IN MOLECULAR MEDICINE (2002)
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
T Wyss-Coray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Roles of the complement system in human neurodegenerative disorders - Pro-inflammatory and tissue remodeling activities
P Gasque et al.
MOLECULAR NEUROBIOLOGY (2002)
Intrarenal synthesis of complement
WD Zhou et al.
KIDNEY INTERNATIONAL (2001)
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease
Y Matsuoka et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis
SK Singhrao et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
